Physician profile
James P Decock
NPI 1720019904
$733.32
in general payments reported to CMS, 2019-2025
18 companies · $294 in 2025
The $294 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25.00 · 2022: $101 · 2023: $114 · 2024: $201 · 2025: $294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $608.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $607.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $112.43 | 2023-2025 | Airsupra, Farxiga |
| Intuitive Surgical, INC. | $99.79 | 2025 | |
| Pfizer INC. | $93.88 | 2022-2025 | |
| Lilly USA, LLC | $74.61 | 2022-2024 | Emgality, Jardiance, Zepbound |
| Inari Medical, INC. | $40.75 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Exact Sciences Corporation | $38.93 | 2023 | Cologuard Collection Kit |
| Novo Nordisk INC | $30.65 | 2025 | Ozempic |
| Abbott Laboratories | $26.64 | 2025 | Freestyle Libre 3 |
| Gilead Sciences, INC. | $25.42 | 2024 | |
| Sanofi Pasteur INC. | $25.00 | 2019 | |
| Medtronic, INC. | $24.50 | 2025 | Inceptiv |
| Lucid Diagnostics INC. | $24.18 | 2023 | |
| Sanofi-Aventis U.S. LLC | $21.93 | 2024 | |
| Amgen INC. | $21.80 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $21.04 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $19.68 | 2025 | Rexulti |
| Merck Sharp & Dohme LLC | $19.26 | 2024 | Proquad, Gardasil 9, M-M-R II |
| Novartis Pharmaceuticals Corporation | $12.83 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Decock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.